← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Advanced Development of Vaccines for Filoviruses
Active
- Institution
- AURO VACCINES LLC, NJ
- Principal investigator
- John Eldridge
- Funding
- $62K
- Duration
- 2020–2026
Moonbase score
Still being scored
Abstract
To support the advanced development of multivalent vaccine candidates for filoviruses and Lassa Fever. This contract aims to formulate a multivalent vaccine that provides protection against several pathogens, including Ebola virus, Marburg virus and Lassa Fever. It may support cGMP manufacture of a stable lyophilized vaccine formulation and preparation and submission of an IND to support eventual clinical evaluation.
LOADING MOONBASE SCORE
Questions for Auro Vaccines Llc
Auro Vaccines Llc hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same topic, scored first.
- NIH · Thomas Jefferson UniversityNot yet scored
Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever
Maja Sundberg · $3.3M · 2017–2027
- NIH · University of Texas Med BR Galveston50
Preclinical development of a vaccine for Nipah virus
Thomas William Geisbert · $1.2M · 2021–2027
- NIH · Thomas Jefferson UniversityNot yet scored
Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models
Dennis A Bente · $789K · 2022–2026